Heng Ren Investments

In a new letter to company management, Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Investments voices the firm’s displeasure over Sinovac insiders' plan to take the company private. On January 28, 2016, after eight years of development, China’s Food and Drug...

The coverage of Chinese management buyout of companies listed on U.S. exchanges has been vast since last year. Joining that large list includes Chinese biotech company Sinovac Biotech Ltd. (NASDAQ: SVA). Sinovac on Monday released two subsequent 6-K. The first 6-K announces the issuance of Good...

Chinese “Go-Private” deals have littered the PR feeds of investors with increased uncertainty in the global macro environment. Often times, executive management teams of these Chinese companies see value taking the company private and re-listing back in China. While nothing would look...